Alivus Life Sciences Limited has informed the Exchange about Schedule of Investors/Analyst Meeting.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alivus Life Sciences Limited has disclosed upcoming meetings with analysts and institutional investors. Two meetings are scheduled: (1) May 25, 2026 at Ambit India Access Titans of Tomorrow Conference in Mumbai for Group/One-on-One discussions, and (2) May 27, 2026 with Abakkus Asset Managers for a One-on-One meeting in Mumbai. Both meetings are in-person. The company notes that schedules may change due to exigencies. This is a routine regulatory disclosure under SEBI Listing Regulations, informing the exchanges about scheduled investor engagement activities.
This is a standard disclosure with no immediate material impact on the stock. The meetings indicate active investor relations engagement with institutional investors, which is routine for listed companies. No price-sensitive information is contained in this filing.